[Retracted] Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis

[已撤稿] 利多卡因通过调节 miR-520a-3p/EGFR 轴在体外和体内抑制视网膜母细胞瘤的进展

阅读:1

Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that flow cytometric (FCM) assay data featured in Figs. 2 and 7B were strikingly similar to FCM data which were ultimately published in a number of other papers in different journals that were written by different authors at different research institutes, including a paper that was submitted on an earlier date to the journal Experimental and Therapeutic Medicine.  Owing to the fact that the contentious data in the above article were found to be strikingly similar to data that have appeared elsewhere in other papers in the scientific literature, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 20: 1333‑1342, 2019; DOI: 10.3892/mmr.2019.10363].

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。